News

Chronic rhinosinusitis with nasal polyps (CRSwNP) inflammatory endotypes are associated with long-term air pollutant and allergen exposure.
Allergy season can be miserable for tens of millions of Americans when trees, grass, and other pollens cause runny noses, ...
Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.
The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.
Pollen is one of the most common triggers of seasonal allergies, according to the Asthma and Allergy Foundation of America. A ...
T he millions of people who suffer from seasonal allergies each year are too familiar with symptoms like sneezing, wheezing, ...
ARS Pharmaceuticals (NASDAQ:SPRY) partners with ALK to co-promote neffy, an epinephrine nasal spray, to 9,000 pediatricians.